NEET Botany Biotechnology and Its Applications MCQs

    Prepare for NEET Biology Biotechnology and Its Applications with MCQs & PYQs on NEET.GUIDE. Access free practice, previous year questions, and expert help to master biotech concepts.

    NEET Questions / Botany / Biotechnology and Its Applications

    22.

    Knockout mice lacking the gene for PrPC^C (prion protein cellular form) are resistant to prion diseases. What can be directly concluded from this observation?

    A

    PrPC^C is sufficient to cause prion diseases.

    B

    PrPC^C is the infectious agent in prion diseases.

    C

    PrPC^C is necessary for the development of prion diseases.

    D

    The absence of PrPC^C enhances the immune response against prions.

    Question Tags

    23.

    Which of the following is a major ethical concern associated with the production of transgenic animals?

    A

    The high cost of producing transgenic animals.

    B

    The low success rate of creating transgenic animals.

    C

    Animal welfare and the potential for unforeseen health problems in the transgenic animals.

    D

    The limited applicability of transgenic animal models to human diseases.

    Question Tags

    26.

    Which of the following is NOT a crucial consideration when designing a CRISPR-Cas9 system for gene therapy targeting a specific genetic disorder?

    A

    Ensuring precise targeting of the Cas9 enzyme to the mutated gene

    B

    Minimizing off-target effects of the Cas9 enzyme

    C

    Choosing an appropriate delivery system for the CRISPR-Cas9 components

    D

    Enhancing the host's immune response to the Cas9 enzyme

    Question Tags

    27.

    In gene therapy for cystic fibrosis, the most significant barrier to successful gene transfer to the lung epithelium is:

    A

    The rapid turnover rate of lung epithelial cells

    B

    The thick mucus layer hindering vector access to target cells

    C

    The lack of suitable viral vectors for lung tissue

    D

    The immune system's rapid clearance of the therapeutic gene

    Question Tags

    29.

    Ex vivo gene therapy involves:

    A

    Directly injecting the therapeutic gene into the patient

    B

    Modifying cells outside the body and then reintroducing them

    C

    Using a viral vector to deliver the gene in vivo

    D

    Modifying germline cells to correct genetic defects

    Question Tags

    30.

    Zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and CRISPR-Cas9 are all tools used in gene editing. What is a key advantage of CRISPR-Cas9 over ZFNs and TALENs?

    A

    Higher target specificity and lower off-target effects

    B

    Easier design and implementation due to RNA-guided targeting

    C

    Ability to target multiple genes simultaneously without modification

    D

    Greater stability and longer lifespan within the target cell

    Question Tags

    Showing 21 to 30 of 599 entries

    company logo